Patents by Inventor Claudia Nune

Claudia Nune has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Semi-static cell culture
    Patent number: 10927344
    Abstract: The present invention relates to cell culture in bioreactors, such as flexible cellbag bioreactors. More specifically the present invention relates to methods for simplifying the production of clinically relevant cell products for use in cell therapy.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: February 23, 2021
    Assignee: Cytiva Sweden AB
    Inventors: Karin Molleryd, Karin Wernersson, Sarah Marie Stone, Claudia Nune, Rolf Kiessling, Tanja Lovgren, Lars Adamsson, Ulrica Eistrand
  • Semi-Static Cell Culture
    Publication number: 20180291341
    Abstract: The present invention relates to cell culture in bioreactors, such as flexible cellbag bioreactors. More specifically the present invention relates to methods for simplifying the production of clinically relevant cell products for use in cell therapy.
    Type: Application
    Filed: May 27, 2016
    Publication date: October 11, 2018
    Inventors: Karin Molleryd, Karin Wernersson, Sarah Marie Stone, Claudia Nune, Rolf Kiessling, Tanja Lovgren, Lars Adamsson, Ulrica Eistrand
  • HPV vaccine comprising peptides from host cell proteins
    Patent number: 8399610
    Abstract: The present invention relates to an immunogenic composition for a human papillomavirus (HPV) vaccine that comprises BAX peptides from BAX host cell proteins and more particularly, a vaccine including those peptides that is directed against cancers that are associated with HPV infections, such as cervical cancer, head and neck cancer and skin cancers. The BAX peptides comprise fragments of BAX host cell proteins that have been targeted for degradation by HPV proteins, such as E6 and E7 and are presented on the surface of HPV infected cells in relatively large amounts. These peptides can be recognised by CTL and elicit an immune response, and are therefore ideal tumour-specific markers. The invention also relates to novel peptide: peptide complexes such as BAX peptide/HLA complexes and their use in a tumour-specific vaccine.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: March 19, 2013
    Assignee: University College Cardiff Consultants Limited
    Inventors: Stephen Tze Kwung Man, Malcolm Mason, Claudia Nunes
  • HPV VACCINE COMPRISING PEPTIDES FROM HOST CELL PROTEINS
    Publication number: 20090317415
    Abstract: The present invention relates to an immunogenic composition for a human papillomavirus (HPV) vaccine that comprises BAX peptides from BAX host cell proteins and more particularly, a vaccine including those peptides that is directed against cancers that are associated with HPV infections, such as cervical cancer, head and neck cancer and skin cancers. The BAX peptides comprise fragments of BAX host cell proteins that have been targeted for degradation by HPV proteins, such as E6 and E7 and are presented on the surface of HPV infected cells in relatively large amounts. These peptides can be recognised by CTL and elicit an immune response, and are therefore ideal tumour-specific markers. The invention also relates to novel peptide: peptide complexes such as BAX peptide/HLA complexes and their use in a tumour-specific vaccine.
    Type: Application
    Filed: August 10, 2009
    Publication date: December 24, 2009
    Inventors: Stephen Tze Kwung Man, Malcolm Mason, Claudia Nunes